Mucosal immunity in HIV infection: What can be done to restore gastrointestinal-associated lymphoid tissue function?

Michael D. George, David Asmuth

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

PURPOSE OF REVIEW: This review describes the impact of HIV infection on gut-associated lymphoid tissue, the mechanisms for persistent gut-associated lymphoid tissue dysfunction despite effective antiretroviral therapy, and potential strategies to restore gut-associated lymphoid tissue function and promote immune reconstitution. RECENT FINDINGS: Recent studies indicate that unresolved microbial translocation and intestinal dysbiosis may continue to promote enteropathy as well as HIV-associated and non-HIV-associated conditions in many HIV patients who otherwise maintain therapeutic control of systemic viral replication. SUMMARY: Several novel therapeutic approaches to reduce intestinal inflammation and mitigate microbial translocation may hold promise for restoring gastrointestinal health and thereby increasing the efficacy of immune reconstitution in HIV-infected patients undergoing antiretroviral therapy.

Original languageEnglish (US)
Pages (from-to)275-281
Number of pages7
JournalCurrent Opinion in Infectious Diseases
Volume27
Issue number3
DOIs
StatePublished - 2014

Fingerprint

Mucosal Immunity
Lymphoid Tissue
HIV Infections
HIV
Dysbiosis
Therapeutics
Inflammation
Health

Keywords

  • dysbiosis
  • gut-associated lymphoid tissue
  • HIV-enteropathy
  • microbial translocation

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases
  • Medicine(all)

Cite this

Mucosal immunity in HIV infection : What can be done to restore gastrointestinal-associated lymphoid tissue function? / George, Michael D.; Asmuth, David.

In: Current Opinion in Infectious Diseases, Vol. 27, No. 3, 2014, p. 275-281.

Research output: Contribution to journalArticle

@article{0a1a9183e8e14913b2e3ab8bb2a2c761,
title = "Mucosal immunity in HIV infection: What can be done to restore gastrointestinal-associated lymphoid tissue function?",
abstract = "PURPOSE OF REVIEW: This review describes the impact of HIV infection on gut-associated lymphoid tissue, the mechanisms for persistent gut-associated lymphoid tissue dysfunction despite effective antiretroviral therapy, and potential strategies to restore gut-associated lymphoid tissue function and promote immune reconstitution. RECENT FINDINGS: Recent studies indicate that unresolved microbial translocation and intestinal dysbiosis may continue to promote enteropathy as well as HIV-associated and non-HIV-associated conditions in many HIV patients who otherwise maintain therapeutic control of systemic viral replication. SUMMARY: Several novel therapeutic approaches to reduce intestinal inflammation and mitigate microbial translocation may hold promise for restoring gastrointestinal health and thereby increasing the efficacy of immune reconstitution in HIV-infected patients undergoing antiretroviral therapy.",
keywords = "dysbiosis, gut-associated lymphoid tissue, HIV-enteropathy, microbial translocation",
author = "George, {Michael D.} and David Asmuth",
year = "2014",
doi = "10.1097/QCO.0000000000000059",
language = "English (US)",
volume = "27",
pages = "275--281",
journal = "Current Opinion in Infectious Diseases",
issn = "0951-7375",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Mucosal immunity in HIV infection

T2 - What can be done to restore gastrointestinal-associated lymphoid tissue function?

AU - George, Michael D.

AU - Asmuth, David

PY - 2014

Y1 - 2014

N2 - PURPOSE OF REVIEW: This review describes the impact of HIV infection on gut-associated lymphoid tissue, the mechanisms for persistent gut-associated lymphoid tissue dysfunction despite effective antiretroviral therapy, and potential strategies to restore gut-associated lymphoid tissue function and promote immune reconstitution. RECENT FINDINGS: Recent studies indicate that unresolved microbial translocation and intestinal dysbiosis may continue to promote enteropathy as well as HIV-associated and non-HIV-associated conditions in many HIV patients who otherwise maintain therapeutic control of systemic viral replication. SUMMARY: Several novel therapeutic approaches to reduce intestinal inflammation and mitigate microbial translocation may hold promise for restoring gastrointestinal health and thereby increasing the efficacy of immune reconstitution in HIV-infected patients undergoing antiretroviral therapy.

AB - PURPOSE OF REVIEW: This review describes the impact of HIV infection on gut-associated lymphoid tissue, the mechanisms for persistent gut-associated lymphoid tissue dysfunction despite effective antiretroviral therapy, and potential strategies to restore gut-associated lymphoid tissue function and promote immune reconstitution. RECENT FINDINGS: Recent studies indicate that unresolved microbial translocation and intestinal dysbiosis may continue to promote enteropathy as well as HIV-associated and non-HIV-associated conditions in many HIV patients who otherwise maintain therapeutic control of systemic viral replication. SUMMARY: Several novel therapeutic approaches to reduce intestinal inflammation and mitigate microbial translocation may hold promise for restoring gastrointestinal health and thereby increasing the efficacy of immune reconstitution in HIV-infected patients undergoing antiretroviral therapy.

KW - dysbiosis

KW - gut-associated lymphoid tissue

KW - HIV-enteropathy

KW - microbial translocation

UR - http://www.scopus.com/inward/record.url?scp=84900512579&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84900512579&partnerID=8YFLogxK

U2 - 10.1097/QCO.0000000000000059

DO - 10.1097/QCO.0000000000000059

M3 - Article

C2 - 24739345

AN - SCOPUS:84900512579

VL - 27

SP - 275

EP - 281

JO - Current Opinion in Infectious Diseases

JF - Current Opinion in Infectious Diseases

SN - 0951-7375

IS - 3

ER -